Aldeyra Therapeutics, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
ALDX on Nasdaq
Location
131 Hartwell Avenue, Suite 320, Lexington, MA

Insiders trading volume in the past year

Aldeyra Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc 10%+ Owner $44M +$2.77M +6.72% Apr 4, 2024
Todd C. Brady President and CEO, Director $4.49M -$581K -11.5% Mar 9, 2024
Stephen Machatha Chief Development Officer $1.12M -$211K -15.8% Aug 12, 2024
Bruce Greenberg Interim Chief Financial Officer $599K -$141K -19.1% Aug 12, 2024
Joshua Reed Chief Financial Officer $478K Mar 30, 2022
Ben Bronstein Director $49.2K Jun 4, 2024
Neal Walker Director $27.6K Jun 4, 2024
Gary Phillips Director $25.8K Jun 4, 2024
Nancy Miller-Rich Director $9.34K Jun 4, 2024
Martin Joyce Director Jun 4, 2024
Michael Alfieri Principal Financial Officer Aug 31, 2024
Douglas Richard Director Jun 4, 2024

Recent Insider Transactions by Companies or Individuals for Aldeyra Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.